Competitive Readiness2019-11-12T12:02:48+00:00

Competitive Readiness

Our competitive readiness capabilities have established Deallus as a trusted partner to many of the world’s leading life sciences companies.

Our capability-building, based on the compelling competitor and market insights we unearth, underpins client strategic decision-making, reinforces competitive mindsets and strengthens brand planning processes to enhance competitive readiness across all relevant divisions, functions and geographies.

CI manager training

Integrating competitive intelligence and the management of CI within an organisation

Deallus Training the trainer

Training the trainer

Developing internal competitive intelligence champions to drive the value of CI throughout the organisation

Building a competitive mindset

Integrating competitive insights into meaningful brand planning

Deallus Training field teams

Training field teams

Sales force training centered on developing a competitive mindset and demystifying competitive challenges

Find out more

Competitive readiness related insight

All Deallus Insight

Let’s talk about NASH

Categories: White Paper|Tags: , |

Several promising candidates are currently competing in a multi-billion-dollar race. NASH, or non-alcoholic steatohepatitis, affects millions of patients world-wide and by 2020 is projected to replace hepatitis C as the number one reason for liver transplantation in the United States. Multiple drug developers have taken on the challenge and a variety of different approaches are currently in the pipeline to tackle this complex, silent disease. Now all eyes are on the finish line to see who will be the first to enter this lucrative and untapped market.

Antimicrobial Resistance

Categories: White Paper|Tags: , |

Lack of innovation surrounding the development of new antibiotics has resulted in an alarming situation, given the rising threat of antimicrobial resistance (AMR). As a result, there is no single or straightforward way to combat AMR, nor to galvanize development of novel antibiotics. Although some positive measures have been introduced, further - and larger scale - action is needed. We take a look at what pharma and the larger healthcare industry needs to do in order to combat this looming threat.

Deallus Keynote at Pharma CiMi.CON EU 2019

Categories: Video|Tags: |

Jonas gives a keynote speech that delves into the importance of strategic intelligence for pharma given today’s dynamic and disruptive marketplace. He explores how competitive and strategic intelligence are related, how to build more strategically focused engagements, and how to help decision makers realize the value in strategic partnerships with their intelligence teams.